115 related articles for article (PubMed ID: 36929215)
41. Down-regulation of Sphk2 suppresses bladder cancer progression.
Sun E; Zhang W; Wang L; Wang A; Ma C; Lei M; Zhou X; Sun Y; Lu B; Liu L; Han R
Tumour Biol; 2016 Jan; 37(1):473-8. PubMed ID: 26224479
[TBL] [Abstract][Full Text] [Related]
42. Co-Delivery of Paclitaxel and shMCL-1 by Folic Acid-Modified Nonviral Vector to Overcome Cancer Chemotherapy Resistance.
Nie W; Wang B; Mi X; Chen J; Yu T; Miao J; Lin Y; Yang T; Ran M; Hong Z; Liu X; Liang X; Qian Z; Gao X
Small Methods; 2021 May; 5(5):e2001132. PubMed ID: 34928100
[TBL] [Abstract][Full Text] [Related]
43. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
44. RNAi-induced K-Ras gene silencing suppresses growth of EC9706 cells and enhances chemotherapy sensitivity of esophageal cancer.
Wang XJ; Zheng YL; Fan QX; Zhang XD
Asian Pac J Cancer Prev; 2012; 13(12):6517-21. PubMed ID: 23464485
[TBL] [Abstract][Full Text] [Related]
45. [Effect and mechanism of siRNA targeting α-enolase gene combined with paclitaxel on proliferation, invasion and apoptosis of hepatocellular carcinoma cell].
Cui H; Gao QQ; Zhuang H; He T; Wan BS; Wang XQ; Zhang L; Huang T; Han F
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1241-1247. PubMed ID: 34915631
[No Abstract] [Full Text] [Related]
46. Proliferation inhibition and apoptosis promotion by dual silencing of VEGF and Survivin in human osteosarcoma.
Gu J; Ji Z; Li D; Dong Q
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):59-67. PubMed ID: 30566604
[TBL] [Abstract][Full Text] [Related]
47. Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells.
Hsiao PW; Chang CC; Liu HF; Tsai CM; Chiu TH; Chao JI
Toxicol Appl Pharmacol; 2007 Jul; 222(1):97-104. PubMed ID: 17540426
[TBL] [Abstract][Full Text] [Related]
48. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
[TBL] [Abstract][Full Text] [Related]
49. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
Le XF; Mao W; He G; Claret FX; Xia W; Ahmed AA; Hung MC; Siddik ZH; Bast RC
J Natl Cancer Inst; 2011 Sep; 103(18):1403-22. PubMed ID: 21813412
[TBL] [Abstract][Full Text] [Related]
50. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis.
Okada T; Ding G; Sonoda H; Kajimoto T; Haga Y; Khosrowbeygi A; Gao S; Miwa N; Jahangeer S; Nakamura S
J Biol Chem; 2005 Oct; 280(43):36318-25. PubMed ID: 16103110
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.
Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G
Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells.
Miao GY; Lu QM; Zhang XL
World J Gastroenterol; 2007 Feb; 13(8):1170-4. PubMed ID: 17451195
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
Xia X; Zhou X
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):36-41. PubMed ID: 29808798
[TBL] [Abstract][Full Text] [Related]
54. [siRNA targeted against survivin induces apoptosis of pancreatic cancer cells].
Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):169-73. PubMed ID: 16503521
[TBL] [Abstract][Full Text] [Related]
55. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
Chen X; Zhang Y; Tang C; Tian C; Sun Q; Su Z; Xue L; Yin Y; Ju C; Zhang C
Int J Pharm; 2017 Aug; 529(1-2):102-115. PubMed ID: 28642204
[TBL] [Abstract][Full Text] [Related]
56. YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.
Li W; Cao Y; Xu J; Wang Y; Li W; Wang Q; Hu Z; Hao Y; Hu L; Sun Y; Xu G; Ao G
J Exp Clin Cancer Res; 2017 Oct; 36(1):144. PubMed ID: 29037225
[TBL] [Abstract][Full Text] [Related]
57. Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma.
Sun X; Chen Y; Zhao H; Qiao G; Liu M; Zhang C; Cui D; Ma L
Drug Deliv; 2018 Nov; 25(1):1718-1727. PubMed ID: 30269613
[TBL] [Abstract][Full Text] [Related]
58. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.
Wang J; Lu Z; Yeung BZ; Wientjes MG; Cole DJ; Au JL
J Control Release; 2014 Mar; 178():79-85. PubMed ID: 24462901
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
60. siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.
Liu WS; Yan HJ; Qin RY; Tian R; Wang M; Jiang JX; Shen M; Shi CJ
Dig Dis Sci; 2009 Jan; 54(1):89-96. PubMed ID: 18594980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
